Literature DB >> 10932231

Fas engagement accelerates liver regeneration after partial hepatectomy.

J Desbarats1, M K Newell.   

Abstract

Fas (CD95) is a receptor involved in induction of apoptotic cell death of Fas-bearing cells, including hepatocytes and T cells. Injection of Fas-specific antibodies into mice leads to fulminant hepatic failure and death. Fas also transduces growth-promoting signals in proliferating T cells, fibroblasts and some tumor cells. Here we show that partial hepatectomy, which triggers the immediate onset of liver regeneration, protected mice against the lethal effects of Fas-specific antibodies and prevented hepatocyte apoptosis in response to Fas engagement in vivo. Furthermore, Fas engagement accelerated liver regeneration after partial hepatectomy. Liver regeneration kinetics were delayed in mutant mice with decreased cell surface Fas expression (lpr mice). In contrast, regeneration was not delayed in lpr-cg mutant mice, which have a Fas mutation that prevents Fas-induced death but not Fas-dependent proliferative stimulation. Our results indicate that Fas engagement on cells in regenerating or healing tissues may promote cell growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932231     DOI: 10.1038/78688

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  62 in total

Review 1.  Death receptors couple to both cell proliferation and apoptosis.

Authors:  Ralph C Budd
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  CD95 and CD95L promote and protect cancer stem cells.

Authors:  Paolo Ceppi; Abbas Hadji; Frederick J Kohlhapp; Abhinandan Pattanayak; Annika Hau; Xia Liu; Huiping Liu; Andrea E Murmann; Marcus E Peter
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

3.  Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Authors:  Arndt Vogel; Joseph E Aslan; Holger Willenbring; Christian Klein; Milton Finegold; Howard Mount; Gary Thomas; Markus Grompe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

4.  Agonistic antibodies to Fas induce a breach in the endothelial lining of the liver and a breakdown in B cell tolerance.

Authors:  M M Newkirk; U Nowak; E Skamene; D Iera; J Desbarats
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

5.  The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.

Authors:  Yun-Ju Lai; Victor T G Lin; Ying Zheng; Etty N Benveniste; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

6.  MORT1/FADD is involved in liver regeneration.

Authors:  Marcus Schuchmann; Felix Ruckert; Jose F Garcia-Lazaro; Andrea Karg; Jurgen Burg; Natalia Knorr; Jurgen Siebler; Eugene E Varfolomeev; David Wallach; Wolfgang Schreiber; Ansgar W Lohse; Peter R Galle
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 7.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 8.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

9.  T cell-derived lymphotoxin regulates liver regeneration.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Peter A Christiansen; Mehtab A Khan; Matthew J Ruddy; Byron Burnette; Salvatore Papa; Guido Franzoso; Sergei A Nedospasov; Yang-Xin Fu; Robert A Anders
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

10.  Increased sinusoidal flow is not the primary stimulus to liver regeneration.

Authors:  Kim E Mortensen; Lene N Conley; Ingvild Nygaard; Peter Sorenesen; Elin Mortensen; Christian Bendixen; Arthur Revhaug
Journal:  Comp Hepatol       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.